Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|December 3, 1999
Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogeneticsS Branford, T P Hughes, Z Rudzki
British Journal of Haematology|July 11, 2000
A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia-positive chronic myeloid leukaemiaS Branford, Z Rudzki, T P Hughes
Leukemia|February 17, 2006
Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABLD M Ross, S Branford, S Moore, et al.
Annals of Clinical Biochemistry|March 1, 1996
Indirect sandwich enzyme-linked immunosorbent assay (ELISA) for plasma apolipoprotein EP Kee, R Bais, S K Sobecki, et al.
Leukemia|September 23, 2006
Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemiaS Branford, N C P Cross, A Hochhaus, et al.
British Journal of Cancer|June 27, 2013
BCR-ABL1 kinase domain mutations may persist at very low levels for many years and lead to subsequent TKI resistanceW T Parker, A L Yeoman, B A Jamison, et al.
Blood Cancer Journal|July 26, 2012
Establishment of a standardized multiplex assay with the analytical performance required for quantitative measurement of BCR-ABL1 on the international reporting scaleJ T Brown, W Laosinchai-Wolf, J B Hedges, et al.
Leukemia|August 28, 2009
Harmonization of molecular monitoring of CML therapy in EuropeM C Müller, N C P Cross, P Erben, et al.
International Journal of Laboratory Hematology|May 25, 2010
Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNAP A Bartley, D M Ross, S Latham, et al.
Leukemia|July 31, 2009
Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive valueA Hochhaus, M C Müller, J Radich, et al.
Pageof 2